全文获取类型
收费全文 | 4813篇 |
免费 | 400篇 |
国内免费 | 252篇 |
出版年
2023年 | 55篇 |
2022年 | 50篇 |
2021年 | 220篇 |
2020年 | 162篇 |
2019年 | 194篇 |
2018年 | 187篇 |
2017年 | 115篇 |
2016年 | 216篇 |
2015年 | 307篇 |
2014年 | 329篇 |
2013年 | 353篇 |
2012年 | 429篇 |
2011年 | 406篇 |
2010年 | 232篇 |
2009年 | 225篇 |
2008年 | 274篇 |
2007年 | 245篇 |
2006年 | 201篇 |
2005年 | 155篇 |
2004年 | 149篇 |
2003年 | 147篇 |
2002年 | 117篇 |
2001年 | 89篇 |
2000年 | 81篇 |
1999年 | 64篇 |
1998年 | 28篇 |
1997年 | 40篇 |
1996年 | 51篇 |
1995年 | 28篇 |
1994年 | 26篇 |
1993年 | 24篇 |
1992年 | 45篇 |
1991年 | 29篇 |
1990年 | 21篇 |
1989年 | 18篇 |
1988年 | 23篇 |
1987年 | 18篇 |
1986年 | 13篇 |
1985年 | 13篇 |
1984年 | 8篇 |
1983年 | 17篇 |
1982年 | 9篇 |
1981年 | 8篇 |
1980年 | 5篇 |
1977年 | 4篇 |
1976年 | 3篇 |
1975年 | 4篇 |
1974年 | 3篇 |
1973年 | 3篇 |
1965年 | 3篇 |
排序方式: 共有5465条查询结果,搜索用时 15 毫秒
31.
32.
33.
多层螺旋CT低剂量扫描在小儿胸部的应用探讨 总被引:5,自引:0,他引:5
目的:评价小儿胸部多层螺旋CT低剂量与常规剂量扫描的图像质量,探讨低剂量扫描在小儿胸部应用的可行性。材料与方法:(1)随机选择肺部感染的患儿30例,先常规剂量(150mAs)扫描,再在感染灶局部加作低剂量扫描,剂量为50,35及15mAs。其他参数为:120kV,床进28.8mm/圈,0.5s/圈,16×1.5mm准直,重建层厚及间隔均为3mm。分别记录不同剂量扫描时的CT权重剂量指数(CTDIw)及剂量长度乘积(DLP)。(2)由2位高年资医师按优、良、合格及不合格的等级盲法评价不同剂量的图像质量,结果进行统计学处理。结果:(1)小儿胸部35mAs和15mAs的CTDIw与常规剂量150mAs的比值分别为23.0%及10.0%,其DLP与常规剂量比值为23.3%和10.0%。(2)图像质量评价结果:150,50,35,15mAs的可诊断图像χ2检验,肺窗P>0.05,纵膈窗P<0.05,提示上述剂量肺窗图像差异无显著性意义,纵膈窗图像差异有显著性意义。用150,50,35mAs的可诊断图像进行χ2检验,P>0.05,提示其差异亦无显著性意义。结论:多层螺旋CT低剂量扫描适用于小儿胸部检查,在保证图像质量的前提下,采用35mAs左右的扫描条件较为适宜。 相似文献
34.
35.
Chunjiang Ye Zhanwang Yu Fanna Kong Suowei Wu Bin Wang 《Plant Molecular Biology Reporter》2005,23(2):167-177
In the present study we propose and test the concept of R-ISSR, a new tool for genomic fingerprinting, mapping, and gene tagging.
The concept is based on the fact that primers for inter-simple sequence repeat (ISSR) and random-amplified polymorphic DNA
(RAPD) analysis elicit different genomic information, and the combined use of these 2 kinds of primers in the same polymerase
chain reaction (PCR) reactions might reveal new genomic loci that could not be detected with either technique alone. The feasibility
of this tool was first electronically simulated with sequence analysis software andArabidopsis chromosome sequence. Next, different combinations of ISSR and RAPD primers were applied in real PCR reactions to detect new
genomic loci in 2 maize lines (Q319 and 1145). Sequencing gels were used to separate PCR products and showed good resolving
ability in comparison with agarose gels. RAPD primers could be successfully used with ISSR primers for the detection of new
genomic loci and applied in a new way for genomic mapping, fingerprinting, and gene tagging. 相似文献
36.
Pseudomonas syringae pv. tagetis, a plant pathogen being considered as a biological control agent of Canada thistle (Cirsium arvense), produces tagetitoxin, an inhibitor of RNA polymerase which results in chlorosis of developing shoot tissues. Although the bacterium is known to affect several plant species in the Asteraceae and has been reported in several countries, little is known of its genetic diversity. The genetic relatedness of 24 strains of P. syringae pv. tagetis with respect to each other and to other P. syringae and Pseudomonas savastanoi pathovars was examined using 16S–23S rDNA intergenic spacer (ITS) sequence analysis. The size of the 16S–23S rDNA ITS regions ranged from 508 to 548 bp in length for all 17 P. syringae and P. savastanoi pathovars examined. The size of the 16S–23S rDNA ITS regions for all the P. syringae pv. helianthi and all the P. syringae pv. tagetis strains examined were 526 bp in length. Furthermore, the 16S–23S rDNA ITS regions of both P. syringae pv. tagetis and P. syringae pv. helianthi had DNA signatures at specific nucleotides that distinguished them from the 15 other P. syringae and P. savastanoi pathovars examined. These results provide strong evidence that P. syringae pv. helianthi is a nontoxigenic form of P. syringae pv. tagetis. The results also demonstrated that there is little genetic diversity among the known strains of P. syringae pv. tagetis. The genetic differences that do exist were not correlated with differences in host plant, geographical origin, or the ability to produce toxin. 相似文献
37.
在医院集中式DICOM医用打印系统中,一台高速DICOM打印机往往连接着多台DICOM主机。由于各主机对输出图像的质量要求不同,如何在打印机端适应主机的要求,控制打印图像质量,是得到令人满意的胶片输出的医用图像的关键。本文以AGFADrystar5500干式相机为例探讨该DICOM医用打印机的图像控制原理和方法,以及在临床上的实际应用。 相似文献
38.
Yun Kong Malene B Vester‐Christensen Katrine T‐B G Schjoldager Kirstine Lavrsen Sally Dabelsteen Nis B Pedersen Lara Marcos‐Silva Ramneek Gupta Eric Paul Bennett Ulla Mandel Søren Brunak Hans H Wandall Steven B Levery Henrik Clausen 《The EMBO journal》2013,32(10):1478-1488
Glycosylation is the most abundant and diverse posttranslational modification of proteins. While several types of glycosylation can be predicted by the protein sequence context, and substantial knowledge of these glycoproteomes is available, our knowledge of the GalNAc‐type O‐glycosylation is highly limited. This type of glycosylation is unique in being regulated by 20 polypeptide GalNAc‐transferases attaching the initiating GalNAc monosaccharides to Ser and Thr (and likely some Tyr) residues. We have developed a genetic engineering approach using human cell lines to simplify O‐glycosylation (SimpleCells) that enables proteome‐wide discovery of O‐glycan sites using ‘bottom‐up’ ETD‐based mass spectrometric analysis. We implemented this on 12 human cell lines from different organs, and present a first map of the human O‐glycoproteome with almost 3000 glycosites in over 600 O‐glycoproteins as well as an improved NetOGlyc4.0 model for prediction of O‐glycosylation. The finding of unique subsets of O‐glycoproteins in each cell line provides evidence that the O‐glycoproteome is differentially regulated and dynamic. The greatly expanded view of the O‐glycoproteome should facilitate the exploration of how site‐specific O‐glycosylation regulates protein function. 相似文献
39.
Mateusz Siedlinski Dustin Tingley Peter J. Lipman Michael H. Cho Augusto A. Litonjua David Sparrow Per Bakke Amund Gulsvik David A. Lomas Wayne Anderson Xiangyang Kong Stephen I. Rennard Terri H. Beaty John E. Hokanson James D. Crapo Christoph Lange Edwin K. Silverman 《Human genetics》2013,132(4):431-441
Cigarette smoking is the major environmental risk factor for chronic obstructive pulmonary disease (COPD). Genome-wide association studies have provided compelling associations for three loci with COPD. In this study, we aimed to estimate direct, i.e., independent from smoking, and indirect effects of those loci on COPD development using mediation analysis. We included a total of 3,424 COPD cases and 1,872 unaffected controls with data on two smoking-related phenotypes: lifetime average smoking intensity and cumulative exposure to tobacco smoke (pack years). Our analysis revealed that effects of two linked variants (rs1051730 and rs8034191) in the AGPHD1/CHRNA3 cluster on COPD development are significantly, yet not entirely, mediated by the smoking-related phenotypes. Approximately 30 % of the total effect of variants in the AGPHD1/CHRNA3 cluster on COPD development was mediated by pack years. Simultaneous analysis of modestly (r 2 = 0.21) linked markers in CHRNA3 and IREB2 revealed that an even larger (~42 %) proportion of the total effect of the CHRNA3 locus on COPD was mediated by pack years after adjustment for an IREB2 single nucleotide polymorphism. This study confirms the existence of direct effects of the AGPHD1/CHRNA3, IREB2, FAM13A and HHIP loci on COPD development. While the association of the AGPHD1/CHRNA3 locus with COPD is significantly mediated by smoking-related phenotypes, IREB2 appears to affect COPD independently of smoking. 相似文献
40.